Theralase Technologies Inc. (TSXV:TLT)
Canada flag Canada · Delayed Price · Currency is CAD
0.1850
-0.0050 (-2.63%)
Aug 26, 2026, 3:58 PM EST

Theralase Technologies Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
554466406977
Market Cap Growth
6.39%-33.43%64.23%-42.29%-9.56%97.37%
Enterprise Value
544466406772
Last Close Price
0.180.170.270.170.320.38

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-31.5031.5031.5031.5031.50
PS Ratio
63.7653.5463.5437.3560.8598.13
PB Ratio
28.0524.5931.7620.9822.4015.11
P/TBV Ratio
28.0524.5931.7620.9822.4015.11

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
63.0953.8363.5337.5259.1391.82

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.220.260.140.200.150.01
Net Debt / Equity Ratio
-0.290.160.010.18-0.33-0.72
Net Debt / EBITDA Ratio
0.16-0.07-0.01-0.080.210.85
Net Debt / FCF Ratio
0.18-0.08-0.01-0.080.200.89
Asset Turnover
0.250.240.320.290.230.10
Inventory Turnover
0.600.590.800.890.970.92
Quick Ratio
1.010.850.990.602.864.56
Current Ratio
1.371.251.611.393.675.71
Return on Equity (ROE)
-242.19%-214.33%-214.26%-182.91%-128.27%-61.98%
Return on Assets (ROA)
-67.86%-77.42%-82.17%-77.21%-64.71%-35.56%
Return on Capital Employed (ROCE)
-182.00%-223.10%-189.70%-208.90%-150.40%-89.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-6.73%-9.43%-6.48%-11.43%-7.56%-5.76%
FCF Yield
-5.78%-7.63%-5.13%-10.28%-7.47%-5.39%
Buyback Yield / Dilution
-5.24%-5.44%-9.14%-5.79%-1.79%-